SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : C-Cube
CUBE 36.52+0.3%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter V who wrote (43267)7/21/1999 1:09:00 AM
From: BillyG   of 50808
 
<<OT>> Placement is critical. It's not always timing....
J&J Plans Contraceptive Patch
.c The Associated Press

NEW YORK (July 20) - Johnson & Johnson, the world leader in the oral contraceptives market, is in the final stages of testing a contraceptive patch for women that is effective for a week, the company disclosed today.

The patch, about the size of a half dollar, would be the newest type of birth control to hit the U.S. market in several years. Women would wear it on their stomach, arms or buttocks. ??????

Early testing shows the patch, called Evra Contraceptive Patch, works as effectively as birth control pills. The company plans to file for U.S. approval early next year.

J&J, the New Brunswick, N.J.-based health care conglomerate most known for selling Band-Aids and Tylenol pain medication, revealed its work on the patch at a meeting of securities analysts in New York today.

J&J officials said the patch has been shown to be safe in tests, and women find it easy to use.

Once the drug is absorbed through the skin, the patch works similarly to birth control pills, officials said.

The patch would seemingly be easier for women to use because they would not have to remember each day to take a pill.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext